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Abstract
Fibroblast cooperation with cancer cells in xenograft
development was investigated by transplanting MDA-
MB-231 cells under the kidney capsule of immuno-
deficient mice. Control fibroblasts and fibroblasts
subjected to stress-induced premature senescence
by treatment with bleomycin were used. In other xeno-
graft models, senescent fibroblasts have shown a
growth-stimulatory effect greater than that of control
cells. In this model, both types of fibroblasts accel-
erated the formation and growth of xenografts. Blood
vessel development, as evidence by von Willebrand
factor staining, was greatly accelerated by the pres-
ence of fibroblasts, and invasion into the kidney was
also increased. Control and senescent fibroblasts had
very similar effects. These actions of fibroblasts were
partially recapitulated in in vitro experiments. Both
control and senescent fibroblasts stimulated the
tubulogenesis of endothelial cells in culture and stimu-
lated the invasion of MDA-MB-231 cells through
Matrigel in vitro. In this xenograft model, in which fibro-
blasts are cotransplanted with a cancer cell into an in-
ternal organ rather than subcutaneously, senescence
was not an important factor in the effects of cotrans-
planted fibroblasts on growth, blood vessel develop-
ment, and invasion. Therefore, cancer promotion by
the senescence of adjacent stromal cells may be
restricted to certain organ and tissue types.
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Introduction
Xenografts of human cancer cells in immunodeficient mice
have been used extensively to probe the behavior of human
cells in an in vivo environment. Although xenografts are
most frequently grown subcutaneously in mice, other ec-
topic or orthotopic sites in the body have often been used
because these sites support more rapid growth and vascu-
larization of cancer cells, and/or support more invasion and
metastasis. In particular, the space beneath the kidney capsule
has been extensively used for cell and tissue transplantation. In
early experiments, an assay for the growth of primary human
tumors was developed using the subrenal capsule space [1].
Following the success of the growth of solid tumor fragments in
the kidney, the technique was adapted for cultured cells by
embedding them in a fibrin clot before inserting them under
the kidney capsule [2]. More recently, the subrenal capsule
space has been used for tissue recombination and recon-
struction, as applied to breast and prostate tissues [3,4]. How-
ever, even before these techniques were introduced, it had
already been demonstrated that cancer cells form xenografts
when injected as cell suspensions beneath the kidney cap-
sule [5,6]. Our studies on adrenocortical cells showed that
injection of cells under the kidney capsule was ideal for cell
survival, permitting functional vascularized tissue formation
from normal primary cells [7–9]. Although the subrenal cap-
sule site is an ectopic site for non–kidney-derived cells,
cancers (such as breast and prostate cancers) grown in this
site acquire histologic features characteristic of these cancers
in their orthotopic sites [10,11].
The excellent survival and growth of cells in this site are
usually attributed to the unique features of the renal vascula-
ture. The kidney has a very high level of blood flow, a positive
interstitial fluid pressure, and a high rate of lymph flow [12,13].
The net effect of this combination of features is that there
is exceptional fluid circulation within the extracellular space
of the kidney; every 5 to 6 seconds, fluid equaling its entire
volume passes through the interstitium [13]. Before trans-
planted cells and tissues become vascularized, whether situ-
ated beneath the kidney capsule or situated elsewhere in the
body, an abundant supply of extracellular fluid supplying
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nutrients and oxygen is likely critical to the success of the
transplant [14]. Thus, conventional blood supply to the
kidney is important for the early survival of transplanted cells;
however, the arterial supply to cells and tissues transplanted
beneath the kidney capsule appears to comprise pre-
dominantly collateral arteries that supply the capsule [15].
The present approach is part of a systematic study of
the features of the subrenal capsule site that make it an
excellent environment for xenograft growth and to compare
the behavior of cells in this site with the behavior of cells
transplanted subcutaneously [16]. One specific aspect is
the role of cotransplanted mesenchymal cells, which may
assist the survival and growth of cancer and normal cells in
this site [4,7–10,17].
In subcutaneous xenograft models, senescence is an
important factor for the promoting effect of cotransplanted
fibroblasts in cancer xenograft growth [18]. In this site in
the body, senescent cell products, such as matrix metallo-
proteinases (MMPs), assist the survival and growth of co-
transplanted cancer cells, such as the human breast cancer
cell line MDA-MB-231 [16,18]. Senescence, which is the
terminal state of cells that have sustained unrepairable
DNA damage, exerts a tumor-suppressor effect on cells that
undergo senescence but can exert a procancer effect on
neighboring cells through secreted senescence-specific
products [19]. The extent to which senescent cells exert
such a protumorigenic effect in vivo is as yet unknown, and
models that explore the potential importance of senescence
in sites other than the subcutaneous site are needed.
Our aims in the present set of experiments were to: 1)
make a reproducible subrenal capsule xenograft model
using MDA-MB-231 cells; and 2) use this model to examine
whether senescence is an important factor in fibroblast-
assisted xenograft growth as it is in subcutaneous xenograft
models. In xenograft experiments, the earliest phases of the
development of the transplant following cell implantation
have not often been studied. Based on prior data on the
early phases of the development of cell transplants [14], we
hypothesized that it would be especially important to study
the early stages of xenograft development.
Materials and Methods
Cell Culture
Normal human newborn foreskin fibroblasts (HCA2) were
obtained from Dr. Olivia Pereira-Smith (University of Texas
Health Science Center, San Antonio, TX). The human breast
cancer cell line MDA-MB-231 was obtained from Dr. Judith
Campisi (Lawrence Berkeley National Laboratory, Berkeley,
CA). Green fluorescent protein (GFP)-expressing MDA231
cells were obtained by transfection with plasmid pEGFP-N1
(BD Biosciences Clontech, Palo Alto, CA). Fibroblasts and
MDA-MB-231 cells were cultured in Dulbecco’s modified
Eagle’s medium (DMEM) supplemented with 10% Cosmic
Calf Serum (HyClone Laboratories, Logan, UT). Human um-
bilical vein endothelial cells (HUVECs; Clonetics brand;
Lonza Bioscience, Walkersville, MD) were used within
seven passages of receipt. GFP-expressing HUVECs were
obtained by transduction with retrovirus pLEGFP-N1 (BD
Biosciences Clontech). All experiments employing HUVECs
were performed in EGM-2 medium (Clonetics brand; Lonza
Bioscience) supplemented with 50 ng/ml vascular endothe-
lial growth factor (R&D Systems, Minneapolis, MN).
Preparation of Stress-Induced Premature Senescence
(SIPS) Fibroblasts
Senescence was induced in HCA2 fibroblasts by incuba-
tion in 10 mg/ml bleomycin sulfate (Fluka, Buchs, Switzer-
land) for 24 hours [20–22]. Following this treatment, cells
were observed to have an enlarged, flattened, senescence-
like morphology. Senescence was evidenced by plating
cells at low density and by demonstrating the absence of
colony growth, and was also assessed by senescence-
associated b-galactosidase staining [23]. SIPS fibroblasts
were used for experiments after 7 days of incubation in reg-
ular medium following 24 hours of incubation in bleomycin.
The medium was changed four times over this period to re-
move all free bleomycin.
Xenografts in Immunodeficient Mice
RAG2/gc/ mice originally purchased from Taconic
(Germantown, NY) were maintained in an animal barrier
facility as a breeding colony. Animals (both males and
females) at the age of > 6 weeks (f 25 g body weight) were
used in these experiments. Procedures were approved by
the institutional animal care committee and were carried
out in accordance with the National Institutes of Health Guide
for the Care and Use of Laboratory Animals. Cell transplan-
tation was performed under tribromoethanol anesthesia [24].
An oblique incision (< 1 cm) was made on the skin parallel
and adjacent to the long axis of the left kidney. Cells to be
implanted were trypsinized and resuspended in cold culture
medium. The total volume (cells and medium) was 10 to
15 ml. Cells were injected under the kidney capsule with a
blunt 25-gauge needle and a glass Hamilton syringe using a
transrenal injection. The kidney was returned to the retro-
peritoneal space. The skin was closed with surgical staples.
Postoperative care for the animals, including the ad-
ministration of analgesics and antibiotics, was performed
as previously described [24]. Animals were sacrificed at
various times following cell transplantation, as described
in Results. GFP-expressing tumors were photographed
under the illumination of a 470-nm light (Lightools Research,
Encinitas, CA).
Histology and Immunohistochemistry
Xenografts were fixed in 4% paraformaldehyde and pro-
cessed conventionally. For staining against von Willebrand
factor (vWf), deparaffinized sections were pretreated with
50 mg/ml proteinase K for 15 minutes at room temperature.
They were then incubated with a 1:500 dilution of rabbit
polyclonal anti–human vWf antibody (Dako, Glostrup, Den-
mark). Bound antibody was visualized with biotinylated
universal secondary antibody (Vector Laboratories, Burlin-
game, CA) according to the manufacturer’s instructions.
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Staining was developed with diaminobenzidine substrate,
and sections were counterstained with dilute hematoxylin.
To quantitate vessel formation, the length of vWf+ vessels
was measured on photographs of sections using Photo-
shop software (Adobe Systems, Inc., San Jose, CA).
An index of invasion was calculated based on measure-
ments made on hematoxylin/eosin–stained sections. Photo-
graphs were analyzed using Photoshop software. The length
of the boundary between the tumor tissue and the kidney
parenchyma (b) and the width of the section (w) was mea-
sured. The invasion index was calculated as: (b  w)/w.
Tubulogenesis Assay
Endothelial cells undergo tubulogenesis in the presence of
cocultured fibroblasts [25]. SIPS or control HCA2 fibroblasts
(2 105) were plated onto collagen-coated coverslips (Becton
Dickinson, Franklin Lakes, NJ). After 4 hours, 105 HUVECs
were plated on top of fibroblast lawns. At various times,
cultures were photographed by fluorescence microscopy;
for this purpose, GFP-expressing HUVECs were used. At
later time points, coverslip cultures were fixed in 70% cold
ethanol. Tubule formation was visualized by staining with anti-
vWf antibody (Dako). Blocking was achieved by incubation
with 1% bovine serum albumin, and fixed cultures were
incubated with 1:400 anti-vWf, followed by incubation with
biotinylated universal secondary antibody (Vector) and devel-
opment with diaminobenzidine substrate. Stained areas,
which represent the extent of tubule formation, were quanti-
tated on randomly selected fields using Photoshop software.
Cell Culture Invasion Assay
Control or SIPS fibroblasts were incubated with serum-
containing culture medium for 24 hours. Control fibroblasts
were plated at high density, so that no significant proliferation
over 24 hours was observed. Conditioned medium was
collected for use in an invasion assay (Matrigel Invasion
Chamber; Becton Dickinson). GFP-expressing MDA-MB-
231 cells (105 cells) were plated on the upper surface of
Matrigel-coated inserts. The conditioned medium was
added to the upper chamber, and DMEM with 5% fetal
bovine serum was added to the lower chamber. After
22 hours, MDA-MB-231 cells that had migrated through
the membrane to the lower surface were counted using
fluorescence microscopy.
Statistical Analysis
One-way analysis of variance (ANOVA) was used to test
for differences between groups.
Results
Fibroblasts Accelerate Xenograft Formation following
Transplantation of MDA-MB-231 Cancer Cells under
the Kidney Capsule
MDA-MB-231 cells were transplanted under the kidney
capsule of immunodeficient mice, either alone or together
with normal human fibroblasts. Fibroblasts were either un-
treated or subjected to SIPS by treatment with bleomycin.
Five days following cell transplantation, MDA-MB-231 cells
injected alone under the kidney capsule formed a mass of
loosely attached cells, and there was prominent fluid accu-
mulation (Figure 1). Some cells attached to the kidney, and
others attached to the distended capsule. In contrast, the
inclusion of normal human fibroblasts, together with MDA-
MB-231 cells, resulted in the formation of a much more solid
tissue structure, with little or no fluid accumulation and no
distension of the capsule. There was no discernable differ-
ence between the appearance of xenografts formed with
SIPS fibroblasts and the appearance of xenografts formed
with control fibroblasts (Figure 1).
Nine days following cell transplantation, the xenografts
were larger than they were at 5 days (Figure 2). Most of the
fluid noticed at 5 days was no longer observed. Xenografts of
MDA-MB-231 cells alone were much smaller than those
formed with fibroblasts. This trend continued up to 15 days.
It was important to demonstrate the reproducibility of this
cotransplant xenograft model so that the effects of fibro-
blasts (control or SIPS) could be precisely assessed. We
found that 9-day xenografts formed from cotransplants of
MDA-MB-231 cells and fibroblasts were very reproducible;
four examples of each type (control and SIPS fibroblasts) are
shown in Figure 1.
At 15 days, xenografts containing fibroblasts had grown
extensively, and much of the kidney had been destroyed.
MDA-MB-231 cells also invaded into the kidney but, at
15 days, had grown much less extensively than xenografts
with fibroblasts.
Fibroblasts Increase the Density of Blood Vessels
in Subrenal Capsule MDA-MB-231 Cell Xenografts
At 5 days, xenografts of MDA-MB-231 cells, with or
without fibroblasts, appeared as white masses under the
kidney capsule. Surface blood vessels were not apparent. At
9 days, many blood vessels were observable in the capsule
(Figure 3). These vessels were observed in xenografts
formed by MDA-MB-231 cells alone and in xenografts
formed with cotransplanted control and SIPS fibroblasts.
These blood vessels supplying the xenografts appear to be
enlarged collateral vessels that normally supply the capsule.
They are usually not visible but become greatly enlarged in
the region of the capsule overlying the xenografts.
Although vessels supplying the capsule enlarged in all
xenografts at f 9 days, we observed differences in the
formation of capillaries and larger vessels within the xeno-
grafts. The density of newly formed blood vessels in the
xenografts was measured. Vessels were visualized by stain-
ing endothelial cells for vWf. The length of vessels per unit
area was measured. Xenografts containing fibroblasts
exhibited a density of vessels much greater than those
formed without fibroblasts (Figure 4). Xenografts formed with
SIPS fibroblasts did not differ in vessel density from those
formed with control fibroblasts.
We investigated whether the effects of fibroblasts ob-
served in MDA-MB-231 xenografts could be reproduced in
studies in vitro. To examine effects on vessel formation, we
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used tubulogenesis in endothelial cell cultures. Under ap-
propriate conditions in culture, endothelial cells form tubules,
a process thought to be the equivalent of capillary formation
in vivo [25]. Fibroblasts were plated in culture to form
confluent lawns. Endothelial cells were then plated on top
of the fibroblasts or plated onto polystyrene tissue culture
dishes without fibroblasts. We used HUVECs that had been
infected with a retrovirus encoding GFP to enable them to
be distinguished from fibroblasts. Cultures were photo-
graphed at various times to examine tubule formation or
were fixed and stained with an anti-vWf antibody. On plastic
tissue culture dishes without fibroblasts, endothelial cells
failed to form tubules. When plated on fibroblasts, endo-
thelial cells formed tubules that were visible both by GFP
fluorescence and by vWf staining (Figure 5). In the initial
period, there were no consistent differences between control
Figure 1. Subrenal capsule xenograft growth with and without cotransplanted fibroblasts. MDA-MB-231 cells (2  106) were injected under the kidney capsule of
immunodeficient mice, alone or with 2  106 HCA2 human fibroblasts. Control fibroblasts (CF) and fibroblasts that have undergone stress-induced premature
senescence (SF) were used. NF = no fibroblasts. The histology of xenotransplants is shown at 5 days (5NF, 5CF, and 5SF), 9 days (9NF, 9CF, and 9SF), and
15 days (15NF, 15CF, and 15SF) following cell transplantation. Four examples of 9-day CF and SF transplants are shown to demonstrate the reproducibility of this
model when cotransplanted fibroblasts are used (see text). Hematoxylin/eosin stain. Original magnification, 40.
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and SIPS fibroblasts. At later times (> 12 days), tubules that
had formed on SIPS fibroblast lawns showed a greater
tendency to disintegrate, whereas this was not as prominent
in tubules formed on control fibroblast lawns. We quanti-
tated tubule formation at various times. Up to 12 days, both
control and SIPS fibroblasts supported the development of
tubules from endothelial cells. After this time, tubules were
stable on control fibroblasts but decreased by up to 50% on
SIPS fibroblasts.
Fibroblasts Increase the Invasiveness of Xenografts
To assess the degree of invasion of xenograft cells into
the kidney, we measured the length of the boundary be-
tween the tumor tissue and the kidney tissue. The shortest
boundary, a straight line, would be formed by tissue that
did not, in any way, invade the kidney. To the extent that
the length of the boundary exceeds that of a straight line, it
can be used as an index of increasing invasiveness. We
chose 9 days as the stage of xenograft development during
which some invasion has started to take place yet the
boundary is still clearly visible. At later times, extensive
destruction of the kidney caused by tumor growth made
Figure 2. Growth of subrenal capsule xenografts with and without
cotransplanted fibroblasts. The sizes of xenografts were calculated from
histologic sections of samples from animals sacrificed at 5 and 9 days
following cell transplantation (five mice per group). Open bar: 2  106 MDA-
MB-231 cells, no fibroblasts. First hatched bar: MDA-MB-231 cells with 2 
106 control fibroblasts. Second hatched bar: MDA-MB-231 cells with SIPS
fibroblasts. Values found to be statistically different are indicated together
with the P value (ANOVA).
Figure 3. Enlargement of blood vessels within the kidney capsule overlying xenografts. GFP-expressing MDA-MB-231 cells were transplanted under the kidney
capsule. (A and AV) 2  106 MDA-MB-231 cells alone. (B and BV) MDA-MB-231 cells with 2  106 control fibroblasts. (C and C V) MDA-MB-231 cells with SIPS
fibroblasts. At 9 days, prominent blood vessels were observed in the capsule. (A–C) Surface appearance. (AV–C V) Appearance under blue light illumination; the
xenograft is fluorescent, and blood vessels appear dark. Original magnification, 20.
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assessment of the location of the xenograft boundary dif-
ficult. At 9 days, invasiveness was higher in xenografts
formed with fibroblasts than in those formed without fibro-
blasts (Figure 6). Xenografts formed with SIPS fibroblasts
showed invasiveness similar to that of xenografts formed
with control fibroblasts.
We were interested to understand whether the increased
invasiveness resulted from factors produced by fibroblasts
that altered the behavior of cancer cells in culture. To study
this, MDA-MB-231 cells were plated on Matrigel-coated
membranes, and medium that had been conditioned by
fibroblasts was added. The fibroblast-conditioned medium
caused a marked increase in the number of MDA-MB-231
cells that migrated through the membrane (Figure 6E). The
medium from SIPS fibroblasts was, however, less effective
than the medium from control fibroblasts.
Discussion
The interaction of stromal and cancer cells in cancer growth
andmalignant properties is recognized as a critically important
factor in tumorigenesis [26–31]. One established method
for investigating stromal–cancer cell interactions is the crea-
tion of xenografts from mixed cell populations. Interestingly,
in xenografts formed from mixed populations of cancer cells
and human fibroblasts, senescence of cotransplanted fibro-
blasts has been found to increase stimulatory effects on
cancer growth [16,18]. These studies have been performed
in subcutaneous cell transplantation experiments. We hypoth-
esized that it would be important to understand the potential
effects of cotransplanted fibroblasts in xenograft growth in an
internal organ, the kidney, using the subrenal capsule space,
an excellent site for cancer cell growth.
To make a quantitative assessment of whether senes-
cence of fibroblasts affects cancer cell growth and proper-
ties, it is necessary to have a reproducible and simple model
for xenograft development. We show here that the subrenal
capsule xenograft model is highly reproducible. Therefore,
relatively small effects of senescent versus control fibro-
blasts would be detected. Although the inclusion of fibro-
blasts greatly accelerated the formation of subrenal capsule
xenografts, careful measurements showed no effect of se-
nescence on the fibroblast effect. This lack of effect was not
the result of a failure of senescent cells to acquire growth-
stimulating properties. We have shown that bleomycin-
treated HCA2 human fibroblasts, the SIPS model used here,
caused a selective increase in MDA-MB-231 xenograft
growth, in comparison to control fibroblasts, when cells are
cotransplanted subcutaneously [16]. Additionally, they
exhibited dramatic changes in gene expression patterns
characteristic of senescence [16]. Thus, we conclude that
senescence-specific products such as MMPs or hepatocyte
Figure 4. Development of blood vessels in xenografts. MDA-MB-231 cells were transplanted under the kidney capsule: (A) 2  106 cells alone. (B) MDA-MB-231
cells with 2  106 control fibroblasts. (C) MDA-MB-231 cells with SIPS fibroblasts. At 9 days, samples were taken for immunohistochemistry. Sections were stained
with an antibody against vWf. Original magnification, 150. (D) The length of vWf + vessels was measured in antibody-stained sections (five mice per group). Open
bar: MDA-MB-231 cells, no fibroblasts. First hatched bar: MDA-MB-231 cells with control fibroblasts. Second hatched bar: MDA-MB-231 cells with SIPS fibroblasts.
Values found to be statistically different are indicated together with the P value (ANOVA).
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growth factor (HGF), which mediate the effects of senescent
cells subcutaneously, are not involved in the effects of fibro-
blasts in the kidney model.
There are a variety of differences in the two sites (sub-
cutaneous and subrenal capsule) that probably account for
these differences. As noted above, the subrenal capsule site
has a very high rate of interstitial fluid flow. However, in the
loose connective tissue under the skin, into which cells are
traditionally implanted for xenograft studies, there is a much
lower rate of interstitial fluid flow. Here senescent cell–
derived products such as MMPs may cause increased cap-
illary permeability and interstitial fluid accumulation [16]. In
the kidney, the actions of cotransplanted senescent cells
probably do not affect the already abundant interstitial fluid
flow. Moreover, the abundant interstitial fluid flow might
rapidly clear fibroblast-secreted products in this site.
Although senescence was not a factor in xenograft
growth, the presence of fibroblasts, both control and SIPS,
greatly accelerated the development of xenografts. The
acceleration of growth by fibroblasts has been previously
observed in subrenal capsule xenografts [4,10,17]; these
studies used control fibroblasts and did not specifically
examine the effects of senescence. We noted here that,
in the absence of fibroblasts, there was an early split of
the kidney capsule away from the xenograft. The major
action of fibroblasts was to consolidate the transplant and
to prevent the splitting of the capsule away from the xeno-
graft. Themode of action of the fibroblasts in this model is not
known. More studies are required to examine whether the
effect is dependent on cell–cell contact, on fibroblast prod-
ucts such as extracellular matrix components, or on para-
crine mediators.
Figure 5. Effects of fibroblasts on tubulogenesis in culture. GFP-expressing HUVECs were plated either alone (105 cells) or onto lawns of human fibroblasts.
Fibroblasts were untreated or had been treated to cause SIPS. The medium used is described in Materials and Methods. HUVECs cultured on fibroblast
lawns formed tubules. (A and B) At early times after plating, fluorescence microscopy was used to observe HUVEC growth patterns (A and B, control fibroblasts;
AV and B V, SIPS fibroblasts; A = 2 days; B = 5 days; original magnification, 15). (C and D) At later time points, vWF staining was used to visualize tubules.
(C and D) Control fibroblasts. (C V and D V) SIPS fibroblasts (C = 12 days; D = 18 days; original magnification, 8). (E) HUVECs cultured alone did not
form tubules (phase contrast; original magnification, 20). (F) The area occupied by tubules in culture was measured at 8, 12, 15, and 18 days. Open symbols:
HUVECs plated on control fibroblasts. Closed symbols: HUVECs plated on SIPS fibroblasts. Each group comprised three replicates; the experiment was repeated
thrice with similar results.
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We observed that the accelerated growth of xenografts
was accompanied by an earlier invasion of cancer cells into
the kidney. The subrenal capsule site readily allows the in-
vasive characteristics of cancer cells to be observed [32,33].
Malignant tissues that invade into the kidney from a sub-
capsular transplant become thoroughly interspersed in the
kidney parenchyma. Glomeruli and tubules are often found
to be surrounded by invading cancer tissues. However,
normal tissues in the same subrenal capsule site maintain
a clear and relatively straight boundary between the trans-
plant tissue and the kidney parenchyma [7–9,32]. In the
present experiments, both normal and senescent fibro-
blasts increased early invasion, although eventually all xeno-
grafts completely invaded and destroyed the kidney. We
investigated whether the stimulatory effect appeared to be
caused by a secreted fibroblast product. In culture, condi-
tioned medium from both control and senescent fibro-
blasts increased the invasion of MDA-MB-231 cells through
a Matrigel-coated membrane. The effect of conditioned me-
dium from control fibroblasts was greater; however, in the
kidney, the stimulatory effects of control and senescent
fibroblasts were indistinguishable. This suggests a negative
effect of a senescent cell–specific product, but further study
will be needed to elucidate the reason for the difference.
The subrenal capsule site also allows the development of
new blood vessels in the cancer tissue to be readily ob-
served. Vessel development in cancers proceeds through
angiogenesis, vasculogenesis, and vessel cooption [34]. In
these experiments, we observed that the accelerated growth
of xenografts in the presence of fibroblasts was accom-
panied by an increased density of vWf+ capillaries. As we
also observed for invasion, there was no distinguishable dif-
ference between control and senescent fibroblasts in the
stimulation of vessel density. Nevertheless, in culture, we
noted differences in the tubulogenesis of endothelial cells
growing on lawns of control or senescent fibroblasts.
HUVECs did not form tubules when grown on tissue culture
plastic, but the growth of endothelial cells on both types of
Figure 6. Invasion of MDA-MB-231 cells into the host kidney. MDA-MB-231 cells were transplanted under the kidney capsule alone (2  106 cells) or with 2  106
control fibroblasts or SIPS fibroblasts. At 5 and 9 days, samples were taken for histologic examination. (A–C) The appearance of the border between MDA-MB-231
cells and the kidney in xenografts without fibroblasts (A) and in xenografts with control fibroblasts (B) or SIPS fibroblasts (C). Original magnification, 400.
(D) Using the procedure described in Materials and Methods, the invasion index was calculated for 5- and 9-day xenografts, with and without fibroblasts. Open bar:
MDA-MB-231 cells, no fibroblasts. First hatched bar: MDA-MB-231 cells with control fibroblasts. Second hatched bar: MDA-MB-231 cells with SIPS fibroblasts.
Values found to be statistically different are indicated together with the P value. (E) Fibroblast effects on MDA-MB-231 cell invasion in vitro. MDA-MB-231 cells
were plated on Matrigel-coated membranes. After 24 hours, the number of cells that had penetrated the membrane was measured (three measurements per
group). Experiments were performed with nonconditioned medium (open bar) or in the presence of conditioned medium from control fibroblasts (first hatched bar)
or SIPS fibroblasts (second hatched bar). Values found to be statistically different are indicated together with the P value (ANOVA).
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fibroblasts resulted in extensive tubule formation. However,
tubules showed a tendency to disintegrate after several
days, which was not observed in tubules formed on control
fibroblasts. Factors specifically secreted by senescent fibro-
blasts could have a long-term negative effect on tubulo-
genesis [35], but further studies are needed to elucidate
this effect. We conclude that both types of fibroblasts stim-
ulate tubulogenesis but that a senescent-specific factor
causes tubule instability.
Overall, in these experiments, we noted that there was an
imperfect correlation between fibroblast effects observed in
culture and their behavior in a well-characterized and repro-
ducible xenograft model in the mouse. These data indicate
that caution must be exercised in interpreting culture models
in terms of cancer biology in vivo. Whereas in vitro models
allow high-throughput screening and detailed investiga-
tions of molecular mechanisms, appropriate validation of
findings in animal models is always required. The lack of
effect of senescence in the subrenal capsule xenograft
model suggests that cancer promotion by the senescence
of adjacent stromal cells may be restricted to certain organ
and tissue types.
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